Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

Dementia is the biggest health challenge facing the UK’s ageing population with 900,000 currently living with the disease and predicted to increase to 1.6 million by 2050. Now, for the first time, a ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...

Dementia therapies may help relieve symptoms, but many different options are available. Some may help more than others.

Monash University researchers are assessing a new drug that could be a game changer for the dementia that has struck US actor Bruce Willis, and ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...